Publications

Publications

Betagenon has in collaboration with Prof. Helena Edlunds’s research group at Umeå University published in vitro, cellular and animal efficacy results as well as clinical results with AMPK activator O304.

JCI Insight: JCI Insight PAN AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and in type 2 diabetic patients
JCI Insight: JCI Insight Supplemental data
Health Europa: Healt Europa AMPK activator O304 A novel treatment for Type 2 diabetes and diabetic kidney disease